LAHO - Lans Holdings, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0006
-0.0001 (-14.29%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.0007
Open0.0007
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0006 - 0.0007
52 Week Range0.0000 - 0.0017
Volume61,664,895
Avg. Volume219,708,631
Market Cap145,372
Beta (3Y Monthly)-11.26
PE Ratio (TTM)N/A
EPS (TTM)-0.1790
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswirelast month

    LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers

    Miami, FL, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Lans Holdings Inc. is pleased to announce that Global Stem Cells Group Inc. (GSCG) www.stemcellsgroup.com has opened two new stem cell offices, one in Valencia, Spain and one in Cochabamba, Bolivia. This brings the total number of global Stem Cell centers to 36 worldwide in 27 countries. The new clinic in Valencia will be the group’s third operation in Spain and the fourth in Europe.

  • GlobeNewswire2 months ago

    Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group

    MIAMI, FL, May 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –  Lans Holdings Inc. (LAHO) is pleased to announce that it has entered into a binding letter of intent to acquire 100% of Global Stem Cells Group Inc. (GSCG). GSCG operates in the global stem cell market which is forecasted by Transparency Market Research to reach $270 billion dollars by 2025 of which roughly 40% or $100 billion will be derived from outside of North America and growing at a 13.8% compounded annual growth rate. GSCG specializes in leading-edge stem cell research, patient application and physician training.

  • We're sorry this is all we were able to find about this topic.